Latest news
Vistagen's second fasedienol dose showed no new safety findings - Stock TitanStock Titan · Thu, 06 Aug 2026 12:30:00 GMTVistagen Therapeutics (NASDAQ: VTGN) granted 180-day Nasdaq bid-price extension - Stock TitanStock Titan · Wed, 05 Aug 2026 20:05:55 GMTL3Harris Keeps ~40% Stake in New Rocketdyne Business After Sale - Stock TitanStock Titan · Tue, 04 Aug 2026 09:26:51 GMTVistagen Therapeutics (Nasdaq: VTGN) names Douglas J. Williamson to board - Stock TitanStock Titan · Fri, 31 Jul 2026 12:49:06 GMTVistagen adds board director with nearly three decades in neuroscience drug development - Stock TitanStock Titan · Fri, 31 Jul 2026 12:30:00 GMTIdentiv Will Skip Q2 Earnings Call Amid Pending Trackonomy Sale - Stock TitanStock Titan · Thu, 30 Jul 2026 20:05:00 GMTNUCOR CORP SEC Filing (Jul 30, 2026) - Stock TitanStock Titan · Thu, 30 Jul 2026 17:44:19 GMTNational Storage Affiliates Trust SEC Filing (Jul 28, 2026) - Stock TitanStock Titan · Tue, 28 Jul 2026 12:10:05 GMT